Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism.

Current opinion in lipidology - 1 Jun 2001

Shachter N S

Abstract excerpt

Apolipoprotein (apo)C-I and apoC-III are constituents of HDL and of triglyceride-rich lipoproteins that slow the clearance of triglyceride-rich lipoproteins by a variety of mechanisms. ApoC-I is an inhibitor of lipoprotein binding to the LDL receptor, LDL receptor-related protein, and VLDL receptor. It also is the major plasma inhibitor of cholesteryl ester transfer protein, and appears to interfere directly with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein C-I
Share to Apolipoprotein C-III
Share to Apolipoproteins C

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hypertriglyceridemia

Share to Lipoproteins

Share to Low Density Lipoprotein Receptor-Related Protein-1

Share to Receptors, Immunologic

Share to Receptors, LDL

Source

Identifiers

PMID: 11353333
DOI: 10.1097/00041433-200106000-00009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism.PMID 11353333Read ↗

A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease.Semantic proximity Read ↗

Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3.Semantic proximity Read ↗

Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.Semantic proximity Read ↗

Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.Semantic proximity Read ↗

[Mutations of APOC3 gene, metabolism of triglycerides and reduction of ischemic cardiovascular events].Semantic proximity Read ↗

Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease.Semantic proximity Read ↗

Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia.Semantic proximity Read ↗

Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations.Semantic proximity Read ↗

ApoC-III helical structure determines its ability to bind plasma lipoproteins and inhibit Lipoprotein Lipase-mediated triglyceride lipolysisSemantic proximity Read ↗

[Apolipoprotein C III and hypertriglyceridemia].Semantic proximity Read ↗

Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.Semantic proximity Read ↗

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.